Johnson & Johnson Baby Powder

Photo: The New York Times

Johnson & Johnson To Discontinue Global Sales Of Talc-Based Baby Powder From 2023

Johnson & Johnson on August 11 said it will terminate global sales of talc-based baby powder in 2023. J&J in 2020 discontinued selling its talc Baby Powder in US and Canada due to demand drop caused by the "misinformation" about the product's safety and a torrent of legal challenges. J&J is facing around 38,000 lawsuits from consumers and their survivors alleging that asbestos exposure in its talc products caused cancer.  

Fri, 12 Aug 2022 - 12:00 PM / by Vidhi Jhunjhunwala

Tags: Johnson & Johnson, talc-based baby powder, Sales, Cancer, lawsuit

Courtesy: India Today

Johnson & Johnson coronavirus vaccine

Photo: Reuters

US CDC Panel To Discuss Blood Clot Issues Due To Johnson and Johnson Vaccine

Amid the persistent blood clot issues with the use of the Johnson and Johnson vaccine, the US Centers for Disease Control and Prevention's (CDC) expert advisers will meet on December 16 to discuss limiting the use of it. Reportedly, the rare issue mostly surfaced in young and middle-aged women. Owing to the problem, nine people have lost their lives, reported The Washington Post, citing a federal official.   

Thu, 16 Dec 2021 - 12:33 PM / by Madhvi Jha

Tags: United States, CDC, Johnson & Johnson, vaccine, blood clots

Courtesy: ANI

Johnson & Johnson Headquarters

Photo: Healthline

Johnson & Johnson Plans To Split Into Two Companies

Healthcare giant Johnson & Johnson announced its plans to split into two different companies on November 12. The company will split its health division that sells Band-Aids and Baby Powder from its large pharmaceuticals unit, reported Reuters. The move came after multinational companies such as Toshiba adopted the same business strategy to simplify their structure. The separation is expected to be completed within 18 to 24 months.

Fri, 12 Nov 2021 - 08:05 PM / by SAM RAHUL RAJASHEKHAR

Tags: Johnson & Johnson, business, Healthcare, Pharmaceuticals

Courtesy: Reuters

J&J's Covid Vaccine

Photo: The Conversation

DCGI Approves J&J's Single-Shot COVID-19 Vaccine In India

Big Pharma Johnson &Johnson's to roll out its single-shot Covid Vaccine in India by the next month. Besides, it is being manufactured at 'Biological E' in Hyderabad. However, the officials have received Emergency Use Approval (EUA) from DCGI. Moreover, Vaccine batches will be sent to Central Drugs Laboratory (CDL) and National Centre for Cell Science (NCCS) for final testing by next week.

Thu, 09 Sep 2021 - 06:00 PM / by Athira Chandran

Tags: Covid Vaccine, Johnson & Johnson, Pharmaceutical, Biological E

Courtesy: News 18

Johnson and Johnson vaccine

Photo: Reuters

J&J Seeks Study For Its Vaccine To Be Applied On Adolescents In India

According to the statement given by the US-based pharmaceutical company, Johnson & Johnson notified that it has looked into the approval of the Central Drugs Standard Control Organisation to conduct a study on its Covid-19 vaccine for adolescents between 12-17 years old in India. Being “imperative”, all the nationals including children should be vaccinated against Covid-19 sooner. Besides, their vaccine is 85% effective in presenting… read-more

Fri, 20 Aug 2021 - 02:42 PM / by Ettishree Shukla

Tags: Covid -19, Coronavirus Vaccines, Johnson & Johnson, India

Courtesy: Zee News

Johnson and Johnson

Photo: DNA

J&J Covid-19 Vaccine Approved For Emergency Use In India

Johnson & Johnson’s single-shot Covid-19 vaccine has been approved for emergency use by India on August 7 amid the growing fear of the upcoming third wave. Health Minister took to Twitter saying, “India expands its vaccine basket! Johnson and Johnson's single-dose Covid-19 vaccine is given approval for Emergency Use in India.” However, the date of arrival of the doses has not been confirmed yet.

Sat, 07 Aug 2021 - 08:42 PM / by Umang Bafna

Tags: Johnson & Johnson, Covid-19 Vaccination centre, Covid-19

Courtesy: The Khaleej Times

Covid-19 vacccine vials.

Photo: DNA

Johnson & Johnson Seeks Approval For Single-Dose Vaccine Launch

US-based pharmaceutical company Johnson & Johnson (J&J) to likely launch a single-dose vaccine against COVID-19 for emergency use in India. Reportedly, the government is yet to approve the proposal. The company also said they aim to launch the vaccine in collaboration with Hyderabad-based Biological E Limited. Notably, the vaccine's phase three clinical trial shows an efficiency of 85% against the Covid-19 strain.

Fri, 06 Aug 2021 - 05:47 PM / by Brijesh Goswami

Tags: Johnson & Johnson, Covid-19 Vaccine, Single-dose, Indian government, vaccine


Drug companies charges for mismanagement

Photo: Healio

US Drug Companies To Pay Billions In Historical Opioids Settlement

A group of 15 US state attorneys general negotiated a settlement deal from large drug companies for $26 billion for allegedly distributing addictive drugs and opioids. The deal became the second-largest cash settlement ever, after the $246 billion tobacco agreement in 1998. Under the deal, the three largest US drug distributors, McKesson Corp, Cardinal Health Inc, and AmerisourceBergen Corp would pay a combined $21bn, while Johnson &… read-more

Thu, 22 Jul 2021 - 09:24 PM / by Prateek Chakradhar

Tags: United States, Johnson & Johnson, Drugs, Attorney General, corporate, health care, Medical Supplies

Courtesy: The Guardian

Johnson and Johnson

Photo: Vox

Traces Of Benzene That Causes Cancer Found In J&J Sunscreens

Johnson & Johnson (J&J) on July 14 said it will recall five of its sunscreen products after benzene, a cancer-causing agent, was detected in its samples. "We voluntarily decided to recall them out of an abundance of caution," J&J said in a statement. Investigations are underway to find out how these chemicals were used in the products. Meanwhile, J&J has requested to stop the usage of the five sunscreens immediately.

Thu, 15 Jul 2021 - 12:07 PM / by Umang Bafna

Tags: Johnson & Johnson, Sunscreen, Cancer, Benzene Chemical

Courtesy: ABC NEWS

Johnson and Johnson vaccine

Photo: Anchorage Daily News

Govt To Soon Approve J&J's Single Dose COVID Jabs At Reasonable Price

India’s principal scientific advisor and co-chair of COVID-19 vaccine task force, K Vijay Raghavan has expected that Centre will soon approve the Johnson and Johnson’s COVID vaccine. Assuring that the pricing and availability will be made transparent, Raghavan hoped the vaccine’s capacity to increases exponentially as Centre looks to boost manufacturing and export of vaccines. J&J recently applied to conduct phase-III clinical trials of… read-more

Tue, 20 Apr 2021 - 07:30 PM / by Sohini Mandal

Tags: Johnson & Johnson, Corona Virus Vaccine, Indian government, COVID-19 outbreak

Courtesy: The Economic Times